Concurrent Immunotherapy and Systemic Therapy With Stereotactic Body Radiation Therapy (SBRT) for Stage IV Cancers (COINSSS IV)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Nivolumab
Related studies linked through entity extraction aliases.
An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
- Status
- RECRUITING
- Phase
- PHASE3
Demographics, Clinical Characteristics and Outcomes in Resected Non-Small Cell Lung Cancer Patients Receiving Immunotherapy in Europe and Canada
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ Adenocarcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Trial of Therapies With IT cDC1s Combined w/ IT Trastuzamab for Her+ or IT Nivolumab for Her- BC LMD
- Status
- RECRUITING
- Phase
- PHASE2
Adaptive Dosing of Immune Checkpoint Inhibitors for Hepatocellular Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Safety and Efficacy of Nivolumab and Imiquimod Combination in Vulvar Squamous Cell Carcinoma Patients
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of SYS6010 Plus Anti-PD-(L)-1 Monoclonal Antibody as Adjuvant Therapy in Non-small Cell Lung Cancer (NSCLC)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
NgFUS NIVO: NeuroNavigation-Guided Focused Ultrasound With Nivolumab in Relapsed and Progressive DMG and Other High Grade Brain Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Evaluation of Esophagogastric Cancer Treatment With Nivolumab in Daily Clinical Practice
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Neoadjuvant Lymph Node Targeted Immunotherapy in Cervical Cancer: a Feasibility Study (NEOLYNC)
- Status
- RECRUITING
- Phase
- PHASE1
Brachytherapy Followed by Nivolumab Prior to Surgery in Rectal Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Treatment Patterns and Characteristics of Patients Prescribed Opdivo Qvantig
- Status
- COMPLETED
- Phase
- N/A
Axelopran and Nivolumab in PD-1-Refractory Metastatic Melanoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Long-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored Study
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE3
Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Evaluating the Addition of Maintenance Immunotherapy Compared to the Usual Treatment of Chemotherapy and Autologous Stem Cell Transplant Alone for High-risk Patients With Relapsed or Refractory Hodgkin Lymphoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2/PHASE3
Phase 2 Study Of Nivolumab Plus AVD In Pediatric, Adolescent, And Young Adult Patients With CHL
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Study of Denikitug (GS-1811) Given Alone or With Nivolumab or Chemotherapy in Adults With Metastatic Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinomas
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)
- Status
- RECRUITING
- Phase
- PHASE3